Tokyo Tape
Sign in
← Medinet

Quarterly report · Q3

2370.TEDINET S100P0C7
Period2021-10-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥470m2021-10-01 → 2022-06-30StandaloneNet sales
Revenue¥683m2020-10-01 → 2021-09-30StandaloneNet sales (5-year summary)
Revenue¥512m2020-10-01 → 2021-06-30StandaloneNet sales
Operating income−¥988m2021-10-01 → 2022-06-30StandaloneOperating income
Operating income−¥792m2020-10-01 → 2021-06-30StandaloneOperating income
Ordinary income−¥984m2021-10-01 → 2022-06-30StandaloneOrdinary income
Ordinary income−¥871m2020-10-01 → 2021-09-30StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥577m2020-10-01 → 2021-06-30StandaloneOrdinary income
Profit before tax−¥985m2021-10-01 → 2022-06-30StandaloneIncome before income taxes
Profit before tax−¥545m2020-10-01 → 2021-06-30StandaloneIncome before income taxes
Net income−¥989m2021-10-01 → 2022-06-30StandaloneProfit loss
Net income−¥843m2020-10-01 → 2021-09-30StandaloneNet income loss (5-year summary)
Net income−¥549m2020-10-01 → 2021-06-30StandaloneProfit loss
Total assets¥6.3bnat 2022-06-30StandaloneAssets
Total assets¥5.4bnat 2021-09-30StandaloneAssets
Total assets¥5.7bnat 2021-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥539mat 2022-06-30StandaloneLiabilities
Total liabilities¥475mat 2021-09-30StandaloneLiabilities
Net assets / equity¥5.7bnat 2022-06-30StandaloneNet assets
Net assets / equity¥4.9bnat 2021-09-30StandaloneNet assets
Net assets / equity¥5.2bnat 2021-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥4.8bnat 2022-06-30StandaloneCash and deposits
Cash and deposits¥4.1bnat 2021-09-30StandaloneCash and deposits
EPS (basic)¥-5.112021-10-01 → 2022-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-1.52022-04-01 → 2022-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-4.882020-10-01 → 2021-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-3.212020-10-01 → 2021-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-0.222021-04-01 → 2021-06-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio91.4%at 2022-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.8%at 2021-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio91.2%at 2021-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued211,730,423at 2022-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued178,750,423at 2021-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued177,730,423at 2021-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2021-10-01 → 2022-06-30−¥386m
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue2021-10-01 → 2022-06-30¥194,000
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue external2021-10-01 → 2022-06-30¥194,000
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentsegment profit2021-10-01 → 2022-06-30−¥425m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue2021-10-01 → 2022-06-30¥470m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue external2021-10-01 → 2022-06-30¥470m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentsegment profit2021-10-01 → 2022-06-30−¥178m
—segment totalrevenue2021-10-01 → 2022-06-30¥470m
—segment totalrevenue external2021-10-01 → 2022-06-30¥470m
—segment totalsegment profit2021-10-01 → 2022-06-30−¥603m
Reconciling Itemsreconcilingsegment profit2020-10-01 → 2021-06-30−¥385m
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue2020-10-01 → 2021-06-30¥143,000
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue external2020-10-01 → 2021-06-30¥143,000
jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segmentsegment profit2020-10-01 → 2021-06-30−¥319m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue2020-10-01 → 2021-06-30¥512m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue external2020-10-01 → 2021-06-30¥512m
jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segmentsegment profit2020-10-01 → 2021-06-30−¥88m
—segment totalrevenue2020-10-01 → 2021-06-30¥512m
—segment totalrevenue external2020-10-01 → 2021-06-30¥512m
—segment totalsegment profit2020-10-01 → 2021-06-30−¥407m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 318
ItemContextValueUnit
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember211707400
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember2117074
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember23023
Number of shares issued shares voting rightsCurrentQuarterInstant211730423
Number of voting rights issued shares voting rightsCurrentQuarterInstant2117074
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member－
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member－
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member－
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member－
Number of shares held in own name treasury shares etcCurrentQuarterInstant－
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant－
Shareholding ratio treasury shares etcCurrentQuarterInstant－
Cash and depositsPrior1YearInstant_NonConsolidatedMember4095689000JPY
Cash and depositsCurrentQuarterInstant_NonConsolidatedMember4776788000JPY
Accounts receivable tradePrior1YearInstant_NonConsolidatedMember219342000JPY
Accounts receivable tradeCurrentQuarterInstant_NonConsolidatedMember168302000JPY
Work in processPrior1YearInstant_NonConsolidatedMember16511000JPY
Work in processCurrentQuarterInstant_NonConsolidatedMember15891000JPY
Raw materials and suppliesPrior1YearInstant_NonConsolidatedMember25360000JPY
Raw materials and suppliesCurrentQuarterInstant_NonConsolidatedMember27511000JPY
Other caPrior1YearInstant_NonConsolidatedMember47949000JPY
Other caCurrentQuarterInstant_NonConsolidatedMember88223000JPY
Current assetsPrior1YearInstant_NonConsolidatedMember4404854000JPY
Current assetsCurrentQuarterInstant_NonConsolidatedMember5076717000JPY
Buildings netPrior1YearInstant_NonConsolidatedMember557397000JPY
Buildings netCurrentQuarterInstant_NonConsolidatedMember498175000JPY
Other net ppePrior1YearInstant_NonConsolidatedMember63096000JPY
Other net ppeCurrentQuarterInstant_NonConsolidatedMember56407000JPY
Property plant and equipmentPrior1YearInstant_NonConsolidatedMember620494000JPY
Property plant and equipmentCurrentQuarterInstant_NonConsolidatedMember554583000JPY
Intangible assetsPrior1YearInstant_NonConsolidatedMember47395000JPY
Intangible assetsCurrentQuarterInstant_NonConsolidatedMember56787000JPY
Investment securitiesPrior1YearInstant_NonConsolidatedMember165704000JPY
Investment securitiesCurrentQuarterInstant_NonConsolidatedMember432558000JPY
Long term loans receivablePrior1YearInstant_NonConsolidatedMember541250000JPY
Long term loans receivableCurrentQuarterInstant_NonConsolidatedMember537500000JPY
Other ioaPrior1YearInstant_NonConsolidatedMember167302000JPY
Other ioaCurrentQuarterInstant_NonConsolidatedMember171720000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant_NonConsolidatedMember-569328000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant_NonConsolidatedMember-564678000JPY
Investments and other assetsPrior1YearInstant_NonConsolidatedMember304928000JPY
Investments and other assetsCurrentQuarterInstant_NonConsolidatedMember577100000JPY
Noncurrent assetsPrior1YearInstant_NonConsolidatedMember972818000JPY
Noncurrent assetsCurrentQuarterInstant_NonConsolidatedMember1188471000JPY
AssetsPrior1YearInstant_NonConsolidatedMember5377672000JPY
AssetsCurrentQuarterInstant_NonConsolidatedMember6265188000JPY
Accounts payable tradePrior1YearInstant_NonConsolidatedMember40912000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2021-09-30pass rounding
balance sheet identitynon_consolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-09-30pass
statement vs summary · net assetsnon_consolidated 2022-06-30pass
statement vs summary · revenuenon_consolidated 2020-10-01/2021-06-30pass
statement vs summary · revenuenon_consolidated 2021-10-01/2022-06-30pass
statement vs summary · total assetsnon_consolidated 2021-09-30pass
statement vs summary · total assetsnon_consolidated 2022-06-30pass